Octreotide for palliative treatment of hepatic metastases from non-neuroendocrine primary tumours: evaluation of quality of life using the EORTC QLQ-C30 questionnaire - Concepedia

Concepedia

Publication | Closed Access

Octreotide for palliative treatment of hepatic metastases from non-neuroendocrine primary tumours: evaluation of quality of life using the EORTC QLQ-C30 questionnaire

17

Citations

19

References

2003

Year

K. Pistevou-Gombaki, Nikos Eleftheriadis, G. Plataniotis, I. Sofroniadis, Vassilis Kouloulias

Palliative Medicine

Abstract

Although further studies are warranted, we consider the use of octreotide a good alternative in palliative treatment of symptomatic liver metastases in patients with end-stage malignant disease.

References

	Year	Citations

Page 1